Try our Advanced Search for more refined results

Expert Analysis

Trade Rep Hints At More CFIUS Scrutiny Of Biotech Deals

By Stephen Mahinka and Carl Valenstein (May 23, 2018, 3:36 PM EDT) -- Foreign acquisitions and investments in the U.S. biotechnology industry have been highlighted by the Trump administration in the voluminous Section 301 report issued March 22, 2018, by the United States Trade Representative. The USTR's primary concern in its investigation was with acquisitions and investments related to technology transfer, intellectual property and innovation in seven industry sectors that the U.S. government for the first time specifically identified as being of significant national security concern....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!